Bank of America Cuts Neumora Therapeutics (NASDAQ:NMRA) Price Target to $7.00
Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by Bank of America from $22.00 to $7.00 in a report released on Monday,Benzinga...
Truist Financial Cuts Ball (NYSE:BALL) Price Target to $73.00
Ball (NYSE:BALL – Free Report) had its price objective decreased by Truist Financial from $78.00 to $73.00 in a report published on Monday,Benzinga reports. Truist...
Insider Selling: Meta Platforms, Inc. (NASDAQ:META) CEO Sells $21,695,565.58 in Stock
Meta Platforms, Inc. (NASDAQ:META – Get Free Report) CEO Mark Zuckerberg sold 35,921 shares of Meta Platforms stock in a transaction on Friday, January 3rd....
Insider Selling: Chewy, Inc. (NYSE:CHWY) CEO Sells 191,096 Shares of Stock
Chewy, Inc. (NYSE:CHWY – Get Free Report) CEO Sumit Singh sold 191,096 shares of the stock in a transaction that occurred on Friday, January 3rd....
Insider Selling: Cloudflare, Inc. (NYSE:NET) CFO Sells $1,707,150.00 in Stock
Cloudflare, Inc. (NYSE:NET – Get Free Report) CFO Thomas J. Seifert sold 15,000 shares of the firm’s stock in a transaction on Friday, January 3rd....
Inhibikase Therapeutics Completes Amendment to Certificate of IncorporationAtlanta, Georgia – Inhibikase Therapeutics, Inc. (NYSE:IKT) recently announced the successful completion of a Special Meeting of Stockholders on January 3, 2025. During this m
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Inhibikase Therapeutics’s...